Medicines Co. Stock
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Repligen Corp. | -4.860% | -7.030% | -22.234% | -19.979% | -20.660% | -36.325% | -40.193% |
| Bausch Health Companies Inc. | 1.070% | -1.245% | -23.724% | -19.330% | -19.264% | -28.044% | -80.935% |
| Viatris Inc. | -0.300% | 7.658% | 15.773% | 28.731% | 26.103% | 18.956% | -12.020% |
Comments
News
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress
On February 13, 2026, Affinity Asset Advisors disclosed a new position in Praxis Precision Medicines (NASDAQ:PRAX), acquiring 185,000 shares in an estimated $54.53 million trade.
According to a SEC
Why Revolution Medicines Stock Plummeted by Almost 17% Today
Monday was generally a good day for the stock market; nevertheless, some titles landed in negative territory. One that plunged well into the red was clinical-stage biotech Revolution Medicines
Why Revolution Medicines Stock Surged by 11% Today
More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That was the dynamic behind the nearly 11% price gain of Revolution Medicines